As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/14/04  Cytrx Corp                        10-K       12/31/03   25:1.7M                                   Bowne of Century City/FA

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    960K 
 2: EX-3.5      Articles of Incorporation/Organization or By-Laws      1     10K 
 3: EX-4.8      Instrument Defining the Rights of Security Holders     7     34K 
 4: EX-10.14    Material Contract                                      1      9K 
 5: EX-10.15    Material Contract                                      1      8K 
 6: EX-10.57    Material Contract                                      5     30K 
 7: EX-10.58    Material Contract                                      8     40K 
 8: EX-10.59    Material Contract                                     25     97K 
 9: EX-10.60    Material Contract                                     15     67K 
10: EX-10.61    Material Contract                                     12     50K 
11: EX-10.62    Material Contract                                     35    122K 
12: EX-10.63    Material Contract                                     80±   282K 
13: EX-10.64    Material Contract                                      4     26K 
14: EX-10.65    Material Contract                                      2     14K 
15: EX-10.66    Material Contract                                     12     58K 
16: EX-10.67    Material Contract                                     44    196K 
17: EX-14.1     Material Foreign Patent                                6     34K 
18: EX-21.1     Subsidiaries of the Registrant                         1      7K 
19: EX-23.1     Consent of Experts or Counsel                          1      9K 
20: EX-23.2     Consent of Experts or Counsel                          1     10K 
21: EX-23.3     Consent of Experts or Counsel                          1      9K 
22: EX-23.4     Consent of Experts or Counsel                          1     10K 
23: EX-23.5     Consent of Experts or Counsel                          1     10K 
24: EX-31       Certification per Sarbanes-Oxley Act (Section 302)  HTML     19K 
25: EX-32       Certification per Sarbanes-Oxley Act (Section 906)  HTML     13K 

EXHIBIT 31

CERTIFICATION

     I, Steven A. Kriegsman, Chief Executive Officer of CytRx Corporation, certify that:

     1.       I have reviewed this annual report on Form 10-K for the fiscal year ended December 31, 2003 of CytRx Corporation;

     2.       Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this annual report;

     3.       Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

     4.       The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

               (a)       Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

               (b)       Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the periods covered by this annual report based on such evaluation; and

               (c)       Disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

     5.       The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

               (a)       All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

               (b)       Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 13, 2004	/s/ STEVEN A. KRIEGSMAN
	Steven A. Kriegsman
	Chief Executive Officer

 

CERTIFICATION

     I, C. Kirk Peacock, Chief Financial Officer of CytRx Corporation, certify that:

     1.       I have reviewed this annual report on Form 10-K for the fiscal year ended December 31, 2003 of CytRx Corporation;

     2.       Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this annual report;

     3.       Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

     4.       The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

               (a)       Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

               (b)       Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the periods covered by this annual report based on such evaluation; and

               (c)       Disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

     5.       The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

               (a)       All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

               (b)       Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 13, 2004	/s/ C. KIRK PEACOCK
	C. Kirk Peacock
	Chief Financial Officer

 

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/14/23  LadRx Corp.                       S-1                   66:6M                                     M2 Compliance LLC/FA
 3/20/23  LadRx Corp.                       10-K       12/31/22   72:6.2M                                   M2 Compliance LLC/FA
 3/23/22  LadRx Corp.                       S-1/A                  3:458K                                   M2 Compliance LLC/FA
 3/23/22  LadRx Corp.                       10-K       12/31/21   72:5.8M                                   M2 Compliance LLC/FA
 8/04/21  LadRx Corp.                       S-1                    3:453K                                   M2 Compliance LLC/FA
 7/13/21  LadRx Corp.                       10-K/A     12/31/20    4:270K                                   M2 Compliance LLC/FA
 3/24/21  LadRx Corp.                       10-K       12/31/20   68:8.1M                                   M2 Compliance LLC/FA